Detalles de la búsqueda
1.
The Impact of FGFR3 Alterations on the Tumor Microenvironment and the Efficacy of Immune Checkpoint Inhibitors in Bladder Cancer.
Mol Cancer
; 22(1): 185, 2023 11 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-37980528
2.
Tertiary lymphoid structure and neutrophil-lymphocyte ratio coordinately predict outcome of pembrolizumab.
Cancer Sci
; 114(12): 4622-4631, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37752769
3.
Pattern of expression of microRNA in patients with radiation induced bladder injury.
Oncology
; 2023 Dec 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38160665
4.
Predicting Objective Response of Pembrolizumab in Platinum-Refractory Urothelial Carcinoma Based on NLR Fluctuation and Liver Metastases.
Oncology
; 2023 Oct 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-37839399
5.
Re-challenging chemotherapy after pembrolizumab in platinum-refractory urothelial carcinoma.
BJU Int
; 131(4): 477-485, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36098556
6.
Nephron-sparing ureteroscopic surgery vs. radical nephroureterectomy: comparable survival-outcomes in upper tract urothelial carcinoma.
World J Urol
; 41(12): 3585-3591, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37924336
7.
Platelet count and dose, but not comorbidities, predict severe neutropenia in cabazitaxel-treated prostate cancer patients: A retrospective observational study.
Int J Clin Pharmacol Ther
; 61(9): 386-393, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37439521
8.
Significance of second progression-free survival in patients with advanced urothelial cancer who received platinum-based combination chemotherapy followed by pembrolizumab.
Int J Urol
; 30(9): 730-736, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-36575640
9.
Real-world effectiveness of nivolumab and subsequent therapy in Japanese patients with metastatic renal cell carcinoma (POST-NIVO study): 36-month follow-up results of a clinical chart review.
Int J Urol
; 30(9): 762-771, 2023 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-37248753
10.
Outcomes of sorafenib treatment of advanced renal cell carcinoma according to IMDC risk criteria: analysis of Japanese real-world data from postmarketing all-patient surveillance of sorafenib.
Future Oncol
; 18(11): 1371-1380, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35023360
11.
Distinct effect of body mass index by sex as a prognostic factor in localized renal cell carcinoma treated with nephrectomy ~ data from a multi-institutional study in Japan ~.
BMC Cancer
; 21(1): 201, 2021 Feb 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-33639880
12.
Risk stratification for the prediction of overall survival could assist treatment decision-making at diagnosis of castration-resistant prostate cancer: a multicentre collaborative study in Japan.
BJU Int
; 127(2): 212-221, 2021 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-32701219
13.
CRISPR Screen Contributes to Novel Target Discovery in Prostate Cancer.
Int J Mol Sci
; 22(23)2021 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-34884583
14.
Adjuvant chemotherapy improves overall survival in patients with localized upper tract urothelial carcinoma harboring pathologic vascular invasion: a propensity score-matched analysis of multi-institutional cohort.
World J Urol
; 38(12): 3183-3190, 2020 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-32065276
15.
Synthetic miR-143 Exhibited an Anti-Cancer Effect via the Downregulation of K-RAS Networks of Renal Cell Cancer Cells In Vitro and In Vivo.
Mol Ther
; 27(5): 1017-1027, 2019 05 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-30930112
16.
A multicenter retrospective study of nivolumab monotherapy in previously treated metastatic renal cell carcinoma patients: interim analysis of Japanese real-world data.
Int J Clin Oncol
; 25(8): 1533-1542, 2020 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-32519026
17.
MicroRNA-143/Musashi-2/KRAS cascade contributes positively to carcinogenesis in human bladder cancer.
Cancer Sci
; 110(7): 2189-2199, 2019 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-31066120
18.
The CANLPH Score, an Integrative Model of Systemic Inflammation and Nutrition Status (SINS), Predicts Clinical Outcomes After Surgery in Renal Cell Carcinoma: Data From a Multicenter Cohort in Japan.
Ann Surg Oncol
; 26(9): 2994-3004, 2019 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31240592
19.
Biological Behavior and Long-Term Outcomes of Carcinoma In Situ in Upper Urinary Tract Managed by Radical Nephroureterectomy.
J Urol
; 199(4): 933-939, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29037861
20.
Outcomes of subsequent non-muscle-invasive bladder cancer treated with intravesical Bacillus Calmette-Guérin after radical nephroureterectomy for upper urinary tract urothelial carcinoma.
BJU Int
; 121(5): 764-773, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281857